Potential applications of thromboelastography in patients with acute and chronic liver disease.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3533209)

Published in Gastroenterol Hepatol (N Y) on August 01, 2012

Authors

R Todd Stravitz1

Author Affiliations

1: Dr. Stravitz is a Professor of Medicine and Medical Director of Liver Transplantation in the Section of Hepatology at the Hume-Lee Transplant Center of Virginia Commonwealth University in Richmond, Virginia.

Associated clinical trials:

Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial (POCKET) | NCT02311985

Articles cited by this

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74

Liver biopsy. Hepatology (2009) 7.61

Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43

The coagulopathy of chronic liver disease. N Engl J Med (2011) 5.63

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl (2005) 2.63

The systemic inflammatory response syndrome in acute liver failure. Hepatology (2000) 2.47

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology (2005) 2.41

Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects. Blood (2010) 2.21

Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol (2011) 1.85

Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol (2009) 1.65

Comparison of thrombelastography with common coagulation tests. Thromb Haemost (1981) 1.58

Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57

Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology (2003) 1.52

Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood (2010) 1.49

Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology (1987) 1.39

Thrombelastography. Transfus Apher Sci (2009) 1.23

Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol (2002) 1.16

Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology (2006) 1.11

Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol (2002) 1.11

Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol (1997) 1.10

Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology (2010) 1.07

Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation (1989) 1.06

Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology (1985) 1.02

Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations. Hepatology (1989) 0.92

Thrombopoietin in acute liver failure. Hepatology (2003) 0.91

Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology (1996) 0.89

Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology (1999) 0.88

Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut (1998) 0.88

Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol (2000) 0.87

Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg (1998) 0.86

Coagulopathy of acute liver failure. Clin Liver Dis (2009) 0.84

Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation. Liver Int (2009) 0.83

Monitoring coagulation and the clinical effects of recombinant factor VIIa. Semin Hematol (2004) 0.81

Quantification of thrombelastographic changes after blood component transfusion in patients with liver disease in the intensive care unit. Anesth Analg (1995) 0.81

The intra-operative use of trasylol (aprotinin) in liver transplantation. Transpl Int (1991) 0.80

A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood. Blood Coagul Fibrinolysis (2008) 0.80

Hemostatic evaluation of patients undergoing liver transplantation. Mayo Clin Proc (1987) 0.77

Use of recombinant factor IX and thromboelastography in a patient with hemophilia B undergoing liver transplantation: a case report. Transplant Proc (2008) 0.77